Developer docs
API playgroundTry for free, no card

Search company profiles

Beaphar

Full company profile

uuid0007l9y

Namestring
Beaphar
Legal namestring
Beaphar BV
Websiteurl
beaphar.com
Company typeenum
Private
Founded yearint
1942
Descriptiontext

Beaphar is a Dutch family-owned pet care company founded in 1942 by Bernard Aa and headquartered in Raalte, Netherlands. The company manufactures and markets pet pharmaceuticals, healthcare products, complete foods, and grooming items for dogs, cats, small animals (rabbits, rodents, guinea pigs), birds, fish, and horses. Its core product lines include anti-parasite treatments (Canishield collars, FIPROtec and COMBOtec spot-ons, Dimethicare bio solutions, Fly Guard), behavioral and calming products (CatComfort, StressLess, No Stress), joint care (Flexifit), nutrition (Care+, Care+ Nature, XtraVital bird food), and grooming (BIO Cosmetics, Universal Shampoo). Production runs across four factories in Raalte, Hedel, and Gainsborough (UK), with a fifth Raalte facility under construction, supported by an R&D laboratory established in 1979.

The company's business model is built on vertically integrated manufacturing sold through a hybrid B2B/B2C channel structure. Beaphar operates its own sales offices in 10 European countries (Netherlands, Germany, UK, France, Belgium, Hungary, Spain, Poland, Norway, Czech Republic) and exports to over 86 countries through a distributor network, while also reaching end consumers directly via its e-commerce website and pet retail stores. Revenue is generated through unit sales of physical products under multiple sub-brands, with no disclosed pricing models or subscription mechanics; B2B sales terms are net-14 days from invoice. Acquisitions have shaped the portfolio: Sherleys (1994, from Ciba Geigy/Novartis), Sinclair Animal and Household Care (2007, fish products / King British), and the Primeval horse care brand. The company remains under Aa family ownership, currently led by Henk Aa and Daan Aa, with no external institutional or private equity backing evidenced.

Short descriptiontext

Beaphar is a Dutch family-owned pet care company founded in 1942 that manufactures pharmaceuticals, supplements, nutrition, and grooming products for dogs, cats, small animals, birds, fish, and horses, selling through European sales offices and distributors in 86+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGreat Wratting, United Kingdom
HQ citystring
Great Wratting
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pet healthcare products, pet pharmaceuticals, anti-parasite treatments, pet nutrition products, animal grooming products
Industry5 codes
PRIMARYHLAMAEAD
Parasiticides & Ectoparasite Control (Flea/Tick/Heartworm)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMALAN
Species-Specific Supplements (Dog/Cat/Other Companion Species)
SECONDARYAFADAFAF
Pet Treats & Chews
Agriculture & Food Production/Animal Feed Manufacturing/Pet Food & Specialty Companion Animal Feed
SECONDARYCRALAHAC
Pet Health & Wellness Retail (Supplements, OTC, Flea/Tick)
SECONDARYCRADAFAJ
Small Animal Food (rabbit/guinea pig/hamster)
NAICS code3 codes
  • Dog and Cat Food Manufacturing311111
  • Animal Food Manufacturing3111
  • Pet and Pet Supplies Retailers459910
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Food And Kindred Products2000
Product category
Pet Care Products
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Pet care product sales
TypeHardware Sales
Description

Beaphar generates revenue through manufacturing and selling pet care products including anti-parasite treatments, healthcare supplements, behavior/calming products, food & snacks, and grooming products for dogs, cats, small animals, and birds through multiple distribution channels.

beaphar.com
2International exports
TypeHardware Sales
Description

Revenue generated from exports through a large network of distributors to over 86 countries worldwide, supported by own sales offices in 10 European countries.

beaphar.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 12 records shown
1King British
Description

Fish products brand including fish feed, water treatments and medicines

beaphar.com
+11 more records
Core offering1 text field

Beaphar manufactures and markets pet pharmaceuticals, healthcare products, and complete foods for dogs, cats, small animals, and birds. The portfolio spans anti-parasite treatments (flea/tick collars, spot-ons, sprays), calming and behavior solutions, joint care supplements, dental care, complete nutrition, and grooming and hygiene products. The company sells through own European sales offices, a global distributor network covering 86+ countries, and pet retail stores.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Canishield collar kills fleas for up to 16 weeks, ticks for up to 6 months, sandflies for up to 5.5 months
+4 more records
Product overview1 text field

Beaphar is a Dutch family-owned pet care company founded in 1942, with over 80 years of heritage. The company offers an extensive product portfolio covering anti-parasite treatments (Canishield®, FIPROtec®, Dimethicare®), behavior and calming solutions (CatComfort®, StressLess®, No Stress Calming Range), healthcare supplements (Flexifit® joint care, Multi-Vit), nutrition (Care+®, XtraVital bird food), and grooming products (shampoos, bathing sand, dental care). Products serve dogs, cats, small animals (rabbits, rodents, guinea pigs), and birds. Through acquisitions, Beaphar has expanded into fish products (King British) and horses (Primeval). The company operates four factories in Raalte, Hedel and Gainsborough, UK, with sales offices across Europe and exports to over 86 countries worldwide.

Product and service3 records
1Beaphar Canishield Collar
CategoryAnti-parasite product
Description

Insecticide collar that slowly releases deltamethrin to kill fleas, ticks and sandflies for dogs for up to 6 months, intended for dogs at risk of leishmaniasis when travelling abroad.

2Beaphar FIPROtec Spot-On
CategoryAnti-parasite product
Description

Spot-on solution for cats and dogs that kills fleas and ticks.

3Beaphar CatComfort
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1Sinclair Animal and Household Care Limited
Strategic tierMinorTypeOthersAnnounced on2007-01-01
Description

Acquisition of British company Sinclair Animal and Household Care Limited, a manufacturer of pet medicines and producer of complete range of fish products including fish feed, water treatments and medicines.

beaphar.com
2Sherleys (Ciba Geigy/Novartis subsidiary)
Strategic tierCoreTypeOthersAnnounced on1994-01-01
Description

Acquisition of British firm Sherleys, a subsidiary of Swiss chemical and pharmaceutical giant Ciba Geigy (now Novartis) in 1994, representing Beaphar's largest acquisition to date.

beaphar.com
3King British
Strategic tierMinorTypeOthers
Description

Daughter company of Beaphar that sells fish products including fish feed, water treatments and medicines.

beaphar.com
Strategic tierMinorTypeOthers
Description

Brand acquired by Beaphar for the horse market, representing expansion into equestrian pet care products.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

US-listed global animal health leader (parent of Bayer Animal Health). Competes head-on with Beaphar's anti-parasite franchise but at vastly larger scale with prescription and OTC portfolios, vaccines, and direct veterinary channel access.

TypeDirect peer
Description

Privately-held French multinational animal health company producing pharmaceuticals, vaccines, and pet care products. Comparable in scale and product breadth across companion animal parasiticides and healthcare.

TypeDirect peer
Description

Privately-held Northern Ireland-based animal health manufacturer of parasiticides, antibiotics, and anti-inflammatories. Comparable as a family-owned, vertically-integrated European pet and livestock pharma peer.

TypeDirect peer
Description

French-listed global animal health company specializing in parasiticides, pet pharmaceuticals, and nutrition. Most direct comparable to Beaphar given overlapping OTC anti-parasite, supplement, and small-animal portfolios and similar mid-sized European heritage.

TypeDirect peer
Description

UK-listed animal pharmaceuticals specialist focused on companion animal endocrinology, dermatology, and parasiticides. Direct comparable in European heritage and pet pharma portfolio composition.

TypeRegional player
Description

Slovenian generic pharma manufacturer with a fast-growing veterinary division spanning parasiticides and pet pharmaceuticals. Comparable as a European mid-cap animal pharma peer with strong Central and Eastern European distribution, similar to Beaphar's regional footprint.

TypeDirect peer
Description

French-listed independent animal health company with a comparable portfolio in pet parasiticides, supplements, dermatology, and small-animal care. Closely comparable in scale, family-influenced ownership history, and European distribution focus.

TypeBroad incumbent
Description

Largest global animal health company, leader in parasiticides, vaccines, and dermatology. Represents the dominant scaled incumbent Beaphar's anti-parasite franchise must compete against in retail and OTC channels.

TypeBroad incumbent
Description

Animal health division of Merck offering parasiticides (Bravecto, NexGard), vaccines, and pharmaceuticals. Scaled incumbent competitor across Beaphar's anti-parasite and broader pet care portfolio.

10Boehringer Ingelheim Animal Health
TypeBroad incumbent
Description

Animal health division of German Boehringer Ingelheim, owning the Frontline franchise and broad companion animal pharma portfolio. Direct competitor to Beaphar in European OTC anti-parasite and broader pet health.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Beaphar

Pet Care Productsbeaphar.com

Beaphar is a Dutch family-owned pet care company founded in 1942 that manufactures pharmaceuticals, supplements, nutrition, and grooming products for dogs, cats, small animals, birds, fish, and horses, selling through European sales offices and distributors in 86+ countries.

What Beaphar does

Beaphar is a Dutch family-owned pet care company founded in 1942 by Bernard Aa and headquartered in Raalte, Netherlands. The company manufactures and markets pet pharmaceuticals, healthcare products, complete foods, and grooming items for dogs, cats, small animals (rabbits, rodents, guinea pigs), birds, fish, and horses. Its core product lines include anti-parasite treatments (Canishield collars, FIPROtec and COMBOtec spot-ons, Dimethicare bio solutions, Fly Guard), behavioral and calming products (CatComfort, StressLess, No Stress), joint care (Flexifit), nutrition (Care+, Care+ Nature, XtraVital bird food), and grooming (BIO Cosmetics, Universal Shampoo). Production runs across four factories in Raalte, Hedel, and Gainsborough (UK), with a fifth Raalte facility under construction, supported by an R&D laboratory established in 1979.

The company's business model is built on vertically integrated manufacturing sold through a hybrid B2B/B2C channel structure. Beaphar operates its own sales offices in 10 European countries (Netherlands, Germany, UK, France, Belgium, Hungary, Spain, Poland, Norway, Czech Republic) and exports to over 86 countries through a distributor network, while also reaching end consumers directly via its e-commerce website and pet retail stores. Revenue is generated through unit sales of physical products under multiple sub-brands, with no disclosed pricing models or subscription mechanics; B2B sales terms are net-14 days from invoice. Acquisitions have shaped the portfolio: Sherleys (1994, from Ciba Geigy/Novartis), Sinclair Animal and Household Care (2007, fish products / King British), and the Primeval horse care brand. The company remains under Aa family ownership, currently led by Henk Aa and Daan Aa, with no external institutional or private equity backing evidenced.

Beaphar firmographics

Firmographics
Name
Beaphar
Legal name
Beaphar BV
Website
https://beaphar.com
Company type
Private
Founded year
1942
Operating status
Operating
Headcount range
11–50 employees
Short description
Beaphar is a Dutch family-owned pet care company founded in 1942 that manufactures pharmaceuticals, supplements, nutrition, and grooming products for dogs, cats, small animals, birds, fish, and horses, selling through European sales offices and distributors in 86+ countries.
Ownership category
akta.pro rank

Beaphar industry classification

Industry
Product category
Pet Care Products
NAICS
Dog and Cat Food Manufacturing (311111), Animal Food Manufacturing (3111), Pet and Pet Supplies Retailers (459910)
SIC
Pharmaceutical Preparations (2834), Food And Kindred Products (2000)
akta.pro industry
PRIMARYHLAMAEAD
Parasiticides & Ectoparasite Control (Flea/Tick/Heartworm)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMALAN
Species-Specific Supplements (Dog/Cat/Other Companion Species)
SECONDARYAFADAFAF
Pet Treats & Chews
Agriculture & Food Production/Animal Feed Manufacturing/Pet Food & Specialty Companion Animal Feed
SECONDARYCRALAHAC
Pet Health & Wellness Retail (Supplements, OTC, Flea/Tick)
SECONDARYCRADAFAJ
Small Animal Food (rabbit/guinea pig/hamster)

Keywords

  • Pet healthcare products
  • Pet pharmaceuticals
  • Anti-parasite treatments
  • Pet nutrition products
  • Animal grooming products

Where Beaphar is headquartered

Location

Headquarters

HQ city
Great Wratting
HQ country
United Kingdom
HQ region
Europe

Offices4 records

Markets served

Beaphar business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pet care product sales: Beaphar generates revenue through manufacturing and selling pet care products including anti-parasite treatments, healthcare supplements, behavior/calming products, food & snacks, and grooming products for dogs, cats, small animals, and birds through multiple distribution channels.
  2. International exports: Revenue generated from exports through a large network of distributors to over 86 countries worldwide, supported by own sales offices in 10 European countries.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Beaphar product offering

Product offering

Core offering

Beaphar manufactures and markets pet pharmaceuticals, healthcare products, and complete foods for dogs, cats, small animals, and birds. The portfolio spans anti-parasite treatments (flea/tick collars, spot-ons, sprays), calming and behavior solutions, joint care supplements, dental care, complete nutrition, and grooming and hygiene products. The company sells through own European sales offices, a global distributor network covering 86+ countries, and pet retail stores.

Product overview

Beaphar is a Dutch family-owned pet care company founded in 1942, with over 80 years of heritage. The company offers an extensive product portfolio covering anti-parasite treatments (Canishield®, FIPROtec®, Dimethicare®), behavior and calming solutions (CatComfort®, StressLess®, No Stress Calming Range), healthcare supplements (Flexifit® joint care, Multi-Vit), nutrition (Care+®, XtraVital bird food), and grooming products (shampoos, bathing sand, dental care). Products serve dogs, cats, small animals (rabbits, rodents, guinea pigs), and birds. Through acquisitions, Beaphar has expanded into fish products (King British) and horses (Primeval). The company operates four factories in Raalte, Hedel and Gainsborough, UK, with sales offices across Europe and exports to over 86 countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • King British: Fish products brand including fish feed, water treatments and medicines
  • Primeval
  • Beaphar Care+
  • Beaphar Canishield
  • Beaphar FIPROtec
  • Beaphar CatComfort
  • Beaphar BIO Cosmetics
  • Beaphar Flexifit
  • Beaphar XtraVital
  • Beaphar StressLess
  • Beaphar No Stress
  • Beaphar COMBOtec

Products and services

  • Beaphar Canishield Collar Insecticide collar that slowly releases deltamethrin to kill fleas, ticks and sandflies for dogs for up to 6 months, intended for dogs at risk of leishmaniasis when travelling abroad.
  • Beaphar FIPROtec Spot-On Spot-on solution for cats and dogs that kills fleas and ticks.
  • Beaphar CatComfort

Quantifiable outcome

  • Canishield collar kills fleas for up to 16 weeks, ticks for up to 6 months, sandflies for up to 5.5 months
  • +4 more outcomes

Companies that use Beaphar

Customer profile

Segments4 records

Ideal customer profiles1 record

Beaphar technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Beaphar partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered minor and core.

  • Sinclair Animal and Household Care LimitedminorOthers · 1 January 2007Acquisition of British company Sinclair Animal and Household Care Limited, a manufacturer of pet medicines and producer of complete range of fish products including fish feed, water treatments and medicines.
  • Sherleys (Ciba Geigy/Novartis subsidiary)coreOthers · 1 January 1994Acquisition of British firm Sherleys, a subsidiary of Swiss chemical and pharmaceutical giant Ciba Geigy (now Novartis) in 1994, representing Beaphar's largest acquisition to date.
  • King BritishminorOthersDaughter company of Beaphar that sells fish products including fish feed, water treatments and medicines.
  • PrimevalminorOthersBrand acquired by Beaphar for the horse market, representing expansion into equestrian pet care products.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Beaphar competitors and assessment

Company assessment

Broad incumbents

  • Elanco Animal Health: US-listed global animal health leader (parent of Bayer Animal Health). Competes head-on with Beaphar's anti-parasite franchise but at vastly larger scale with prescription and OTC portfolios, vaccines, and direct veterinary channel access.
  • Zoetis: Largest global animal health company, leader in parasiticides, vaccines, and dermatology. Represents the dominant scaled incumbent Beaphar's anti-parasite franchise must compete against in retail and OTC channels.
  • MSD Animal Health (Merck): Animal health division of Merck offering parasiticides (Bravecto, NexGard), vaccines, and pharmaceuticals. Scaled incumbent competitor across Beaphar's anti-parasite and broader pet care portfolio.
  • Boehringer Ingelheim Animal Health: Animal health division of German Boehringer Ingelheim, owning the Frontline franchise and broad companion animal pharma portfolio. Direct competitor to Beaphar in European OTC anti-parasite and broader pet health.

Direct peers

  • Ceva Santé Animale: Privately-held French multinational animal health company producing pharmaceuticals, vaccines, and pet care products. Comparable in scale and product breadth across companion animal parasiticides and healthcare.
  • Norbrook Laboratories: Privately-held Northern Ireland-based animal health manufacturer of parasiticides, antibiotics, and anti-inflammatories. Comparable as a family-owned, vertically-integrated European pet and livestock pharma peer.
  • Virbac: French-listed global animal health company specializing in parasiticides, pet pharmaceuticals, and nutrition. Most direct comparable to Beaphar given overlapping OTC anti-parasite, supplement, and small-animal portfolios and similar mid-sized European heritage.
  • Dechra Pharmaceuticals: UK-listed animal pharmaceuticals specialist focused on companion animal endocrinology, dermatology, and parasiticides. Direct comparable in European heritage and pet pharma portfolio composition.
  • Vetoquinol: French-listed independent animal health company with a comparable portfolio in pet parasiticides, supplements, dermatology, and small-animal care. Closely comparable in scale, family-influenced ownership history, and European distribution focus.

Regional players

  • Krka: Slovenian generic pharma manufacturer with a fast-growing veterinary division spanning parasiticides and pet pharmaceuticals. Comparable as a European mid-cap animal pharma peer with strong Central and Eastern European distribution, similar to Beaphar's regional footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Beaphar social profiles

Digital presence

Beaphar financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Beaphar leadership team

Management profile

Number of profiles

Profiles3 records

Beaphar subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Beaphar funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Beaphar M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beaphar

What does Beaphar do?

Beaphar manufactures and markets pet pharmaceuticals, healthcare products, and complete foods for dogs, cats, small animals, and birds. The portfolio spans anti-parasite treatments (flea/tick collars, spot-ons, sprays), calming and behavior solutions, joint care supplements, dental care, complete nutrition, and grooming and hygiene products. The company sells through own European sales offices, a global distributor network covering 86+ countries, and pet retail stores.

Is Beaphar a public or private company?

Beaphar is a private company. It is classified as family owned and is currently operating.

When was Beaphar founded?

Beaphar was founded in 1942. It employs 11 to 50 people.

Where is Beaphar based?

Beaphar is headquartered in Great Wratting, United Kingdom, in the Europe region.

How does Beaphar make money?

Two revenue lines are on record. Pet care product sales are the primary driver. The others are international exports.

Who are Beaphar's main competitors?

Broad incumbents on record are Elanco Animal Health, Zoetis, MSD Animal Health (Merck) and Boehringer Ingelheim Animal Health. Direct peers are Ceva Santé Animale, Norbrook Laboratories, Virbac, Dechra Pharmaceuticals and Vetoquinol. Krka is listed as a regional player.

Does Beaphar have an API?

No public API is recorded for Beaphar.

What industry is Beaphar in?

Beaphar's product category is Pet Care Products. Its primary akta.pro industry code is HLAMAEAD, Parasiticides & Ectoparasite Control (Flea/Tick/Heartworm), with a secondary code of HLAMALAN, Species-Specific Supplements (Dog/Cat/Other Companion Species). Its NAICS code is 311111 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
IndexBoxReport - IndexBox - Prices, Size, Forecast, and CompaniesIndexBox published a comprehensive market analysis report on the Netherlands portable pet deodorizing spray market, estimating retail sales of EUR 25-40 million in 2025 with 7-9% compound annual growth from 2020-2025 and projected 5-8% growth through 2035. The market is structurally driven by high pet ownership density (approximately 50% of Dutch households), urbanization in the Randstad corridor, and consumer shift toward natural/enzyme-based premium formulations, which now account for 30-35% of category value. The report identifies a fragmented competitive landscape with global brand owners (Church & Dwight's Arm & Hammer and Nature's Miracle brands; SC Johnson's Febreze Pet), Dutch market leader Beaphar, and aggressive private-label expansion by retailers Albert Heijn and Jumbo, while noting that 65-75% of supply is imported from Germany and Belgium.openPR.comPet Grooming Products Market to Reach $46.50 Billion by 2034, Growing at 8.5% CAGRThe global pet grooming products market is projected to grow from $22.31 billion in 2025 to $46.50 billion by 2034, representing a compound annual growth rate of 8.5% during the 2026–2034 forecast period. Growth is driven by rising pet ownership, premiumization trends, increasing demand for eco-friendly and at-home grooming solutions, and technological innovation in grooming tools. Key market players including Ancol Pet Products Limited, Beaphar, Wahl Clipter, The Hartz Mountain Corporation, and Johnson are focusing on product innovation and sustainability to strengthen their positions.openPR.comPet Cosmetics Market Growth to Accelerate in Forecast Period 2025-2035 | Beaphar ,Wahl Clipper Corporation ,Spectrum Brands ,Nature's Specialties ,Bio-GroomThe global pet cosmetics market is projected to grow from USD 1.84 billion in 2025 to USD 3.91 billion by 2035, a CAGR of about 7.1%. The report also profiles key players and segments by pet type, product, and distribution channel.Horse & HoundPlaque off! The best toothbrushes to support your dog’s oral hygiene and banish dental diseaseThe article presents a curated list of dog toothbrushes and dental care kits from brands such as Arm & Hammer, Beaphar, Techmira, Vet’s Best, Virbac, and MDC. It highlights specific product features, including manual and electric options, to help owners manage canine oral hygiene and prevent dental disease. The content provides purchasing links for these products in the UK and US markets.Business Wire BlogGlobal Pet Dietary Supplements Market 2019-2023 | Evolving Opportunities with Ark Naturals Co. & Beaphar Group | TechnavioTechnavio forecasts the global pet dietary supplements market to grow by USD 624.3 million from 2019 to 2023, at a CAGR of over 5%. Growth is driven by high-quality product launches and a trend toward organic supplements. The report also profiles major vendors including Ark Naturals, Beaphar, and Boehringer Ingelheim.PR NewswireLpet opens overseas business focusing on cross-border ecommerceLpet, a Chinese pet industry B2B procurement platform, has expanded its cross-border e-commerce business by establishing bonded warehouses in Hangzhou, Hong Kong, and Tianjin and signing agency agreements with international pet product brands. The company, founded in 2014, has raised a total of 250 million yuan across two financing rounds (100 million yuan in July 2017 and 150 million yuan in April 2018). Lpet has secured China General Agent rights for Japanese brand TAURUS and established partnerships with over 50 companies including German Gimpet, Belgian VIYO, Canadian MEGAMZAON, and international brands such as Orijen, ACANA, ANNAMAET, and Beaphar.PR NewswireGlobal Wet Pet Food Market 2017-2021Technavio forecasts the global wet pet food market to grow at a CAGR of 5.66% from 2017 to 2021. The report covers market segments by geography and lists key vendors including Beaphar, Blue Buffalo, and Mars. It also notes market drivers such as increased pet ownership and premiumization.PR NewswireGlobal Pet Grooming Market 2016-2020Technavio released a market research report forecasting the global pet grooming market to grow at a CAGR of 4.19% between 2016 and 2020, driven primarily by increased pet ownership and health awareness. The study identifies key vendors such as Ancol Pet Products, Beaphar, and Ferplast, while noting challenges like rising pet allergies among caregivers. North America is highlighted as the leading regional market, with baby boomers significantly contributing to demand.